Paloma Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,351
| Closed | -$855K | – | 1227 |
|
|
2024
Q2 | $855K | Buy |
+4,351
| New | +$899K | 0.02% | 558 |
|
|
2024
Q1 | – | Sell |
-1,088
| Closed | -$229K | – | 814 |
|
|
2023
Q4 | $229K | Buy |
+1,088
| New | +$232K | 0.01% | 603 |
|
|
2023
Q1 | – | Sell |
-1,321
| Closed | -$222K | – | 780 |
|
|
2022
Q4 | $222K | Buy |
+1,321
| New | +$230K | 0.01% | 683 |
|
|
2022
Q2 | – | Sell |
-3,716
| Closed | -$883K | – | 1210 |
|
|
2022
Q1 | $883K | Sell |
3,716
-1,273
| -26% | -$299K | 0.03% | 485 |
|
|
2021
Q4 | $1.14M | Sell |
4,989
-32,787
| -87% | -$7.21M | 0.02% | 639 |
|
|
2021
Q3 | $7.3M | Buy |
37,776
+337
| +0.9% | +$68.3K | 0.18% | 72 |
|
|
2021
Q2 | $7.96M | Buy |
37,439
+32,373
| +639% | +$6.84M | 0.14% | 115 |
|
|
2021
Q1 | $1.03M | Buy |
+5,066
| New | +$998K | 0.02% | 669 |
|
|
2020
Q4 | – | Sell |
-16,114
| Closed | -$2.7M | – | 1722 |
|
|
2020
Q3 | $2.7M | Sell |
16,114
-58,407
| -78% | -$9.84M | 0.07% | 295 |
|
|
2020
Q2 | $12.1M | Buy |
74,521
+66,212
| +797% | +$11.9M | 0.21% | 79 |
|
|
2020
Q1 | $1.44M | Sell |
8,309
-4,274
| -34% | -$851K | 0.08% | 205 |
|
|
2019
Q4 | $2.53M | Buy |
+12,583
| New | +$2.58M | 0.04% | 494 |
|
|
2019
Q3 | – | Sell |
-1,404
| Closed | -$273K | – | 2003 |
|
|
2019
Q2 | $273K | Sell |
1,404
-10,989
| -89% | -$2.03M | ﹤0.01% | 1354 |
|
|
2019
Q1 | $2.04M | Buy |
+12,393
| New | +$2.19M | 0.05% | 437 |
|
|
2018
Q4 | – | Sell |
-3,332
| Closed | -$567K | – | 1336 |
|
|
2018
Q3 | $567K | Buy |
3,332
+139
| +4% | +$23.4K | 0.01% | 974 |
|
|
2018
Q2 | $523K | Sell |
3,193
-31,027
| -91% | -$5.07M | 0.01% | 1008 |
|
|
2018
Q1 | $5.53M | Buy |
34,220
+32,012
| +1,450% | +$5.1M | 0.09% | 181 |
|
|
2017
Q4 | $322K | Sell |
2,208
-92
| -4% | -$13.1K | ﹤0.01% | 1513 |
|
|
2017
Q3 | $312K | Sell |
2,300
-14,000
| -86% | -$1.77M | ﹤0.01% | 1779 |
|
|
2017
Q2 | $2.04M | Sell |
16,300
-36,640
| -69% | -$4.38M | 0.02% | 736 |
|
|
2017
Q1 | $6.29M | Buy |
52,940
+35,142
| +197% | +$4.23M | 0.08% | 240 |
|
|
2016
Q4 | $2.05M | Buy |
17,798
+2,374
| +15% | +$264K | 0.02% | 658 |
|
|
2016
Q3 | $1.61M | Sell |
15,424
-197,958
| -93% | -$20.7M | 0.02% | 664 |
|
|
2016
Q2 | $20.8M | Sell |
213,382
-29,536
| -12% | -$2.79M | 0.23% | 40 |
|
|
2016
Q1 | $23.3M | Buy |
242,918
+231,384
| +2,006% | +$21.1M | 0.38% | 31 |
|
|
2015
Q4 | $1.04M | Sell |
11,534
-7,569
| -40% | -$712K | 0.03% | 654 |
|
|
2015
Q3 | $1.77M | Buy |
19,103
+16,706
| +697% | +$1.59M | 0.04% | 378 |
|
|
2015
Q2 | $223K | Sell |
2,397
-8,457
| -78% | -$789K | ﹤0.01% | 1492 |
|
|
2015
Q1 | $1.03M | Buy |
+10,854
| New | +$1.01M | 0.03% | 482 |
|
|
2014
Q3 | – | Sell |
-4,429
| Closed | -$314K | – | 1046 |
|
|
2014
Q2 | $314K | Buy |
+4,429
| New | +$312K | 0.01% | 783 |
|
|
2013
Q3 | – | Sell |
-3,604
| Closed | -$274K | – | 952 |
|
|
2013
Q2 | $274K | Buy |
+3,604
| New | +$236K | 0.02% | 710 |
|
Other funds holding CME
Paloma Partners's CME Position: Q3 2024 in Review
Paloma Partners sold out of CME Group (CME) in Q3 2024, closing a stake of 4,351 shares — an estimated $855K sold.
Paloma Partners first reported a position in CME in Q2 2013 and held it in 31 quarters. The position peaked at $23.3M in Q1 2016. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.
- Paloma Partners reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
- Paloma Partners sold 4,351 CME Group shares in Q3 2024, an estimated $855K.
- Paloma Partners first reported a position in CME Group in Q2 2013 and held it in 31 quarters.
- Paloma Partners's CME Group position peaked at $23.3M in Q1 2016.
- 1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.
Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.